The role of mannose-binding lectin (MBL) in paediatric oncology patients with febrile neutropenia
- 31 May 2006
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 42 (7) , 909-916
- https://doi.org/10.1016/j.ejca.2005.10.027
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: A systematic review of randomised controlled trialsEuropean Journal Of Cancer, 2005
- Infections in Patients with Febrile Neutropenia: Epidemiology, Microbiology, and Risk StratificationClinical Infectious Diseases, 2005
- ROLE OF C5A IN INFLAMMATORY RESPONSESAnnual Review of Immunology, 2005
- Association of MBL gene polymorphisms with major bacterial infection in patients treated with high-dose chemotherapy and autologous PBSCTGenes & Immunity, 2005
- Mechanism of Complement Activation and Its Role in the Inflammatory Response After Thoracoabdominal Aortic Aneurysm RepairCirculation, 2003
- Infusion of plasma-derived mannan-binding lectin (MBL) into MBL-deficient humansBiochemical Society Transactions, 2003
- Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantationBlood, 2002
- Mannose-binding lectin: the pluripotent molecule of the innate immune systemImmunology Today, 1996
- The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategiesThe Journal of Pediatrics, 1991
- ASSOCIATION OF LOW LEVELS OF MANNAN-BINDING PROTEIN WITH A COMMON DEFECT OF OPSONISATIONThe Lancet, 1989